AFFiRiS is an innovative biotechnology company developing first-in-class antigen specific vaccines for the prevention and treatment of chronic illnesses.

Using its proprietary AFFITOME® – technology, AFFiRiS is able to develop customised peptide-based vaccines targeting Alzheimer’s disease, Parkinson’s disease, atherosclerosis, diabetes and other diseases with unmet medical needs.

AFFiRiS AG
Karl-Farkas-Gasse 22
1030 Vienna
Austria
Building: SOLARIS – Map

+43 (0) 1 798 15 75 300